Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds HTLZF.
No tracked institution reports a position in HTLZF as of their last filing.
No one on the platform has traded HTLZF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $95M | +9.7% | $0.08 | $0.08–$0.08 | 19.6× | 1 |
| 2027 | $105M | +10.0% | $0.09 | $0.09–$0.09 | 16.9× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-11-14 | $-0.00 | $-0.01 | -1104.8% |
| 2024-08-14 | $-0.00 | $-0.00 | -100.6% |
| 2024-05-14 | $-0.00 | $-0.01 | -400.0% |
| 2023-11-13 | $0.01 | $-0.01 | -200.0% |
| 2023-08-17 | $-0.00 | $-0.00 | -100.7% |
| 2023-05-15 | $0.01 | $0.00 | -94.0% |
| 2023-03-30 | $0.01 | $0.01 | -18.7% |
| $255M |
| — |
| EKDHFEKF Diagnostics Holdings plc | $0.34 | +0.00% | $146M | — |
| FPHAFFaron Pharmaceuticals Oy | $3.30 | +0.00% | $210M | — |
Source: Financial Modeling Prep · peers by sector/industry